Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
61 Results Found
Advocacy Issue: 340B Drug Pricing Program
The 340B program has worked successfully for over 30 years to allow eligible providers to stretch limited federal resources to provide more comprehensive programs and services to more patients. This is exactly what Congress intended when it created the program in 1992.
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
340B Advocacy Alliance Bulletin - April 24, 2025
340B Advocacy Alliance Bulletin for April 24, 2025.
White House issues executive order on drug pricing
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
TAKE ACTION: Urge Lawmakers to Reject Medicaid Cuts, Protect Access to Care
With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.
Contact Your Lawmakers and Urge Them to Extend Key Health Care Policies Set to Expire Next Month
Please ask your senators and representatives to prevent Medicaid disproportionate share hospital payment cuts from taking effect; extend enhanced low-volume adjustment and Medicare-dependent hospital programs that expand access to care in rural areas; and extend telehealth and hospital-at-home waivers.
AHA 340B Advocacy Alliance
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.
340B AHA Advocacy Alliance - March 7, 2025
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
AHA 340B Advocacy Alliance Bulletin: HRSA Issues Final Warning to J&J on 340B Proposal
The Health Resources and Services Administration today sent a final warning letter to Johnson & Johnson urging the company to inform the agency by Monday, Sept. 30 that it would halt its proposed 340B rebate model scheduled to go into effect next month.
Washington update panel discusses legislative priorities for rural health care
AHA President and CEO Rick Pollack joined AHA’s Chad Golder, senior vice president and general counsel, Travis Robey, vice president of political affairs, and Shannon Wu, director of payment policy, for a discussion on the ever-shifting landscape of health care affairs on Capitol Hill.